Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Dermatology | Rheumatology | Family Medicine
Search Medical Condition
Psoriasis and Psoriatic Disorders Clinical Trials
A listing of Psoriasis and Psoriatic Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (63) clinical trials
A randomized, double-blind, placebo-controoled, parallel-group, multicenter study to explore changes in subcutaneous adipose tissue and modulation of skin inflammation after 12 weeks of treatment with secukinumab in adult patients with moderate to severe plaque psoriasis.
52 week study. Cosentyx vs placebo for 12 weeks, open label week 12-52.
A phase 3, multi-center, randomized, placebo controlled, double-blind, study of the efficacy and safety of apremilast (CC-1004) in subjects with moderate to severe plaque psoriasis of the scalp.
Otezla vs. Placebo for 16 weeks, 2:1 Open label week 16-32 4 week followup
A phase 2A, randomized, double-blind, placebo-controoled, study to evaluate safety and efficacy of PF-06700841 in subjects with moderate to severe plaque psoriasis.
12 week double-blind study with a 8 week followup.
A Randomized, Double-Blind Study Comparing TOLMAR Calcipotriene and Betamethasone Suspension to Reference Listed Drug in the Treatment of Scalp Psoriasis
This study will be conducted to evaluate the therapeutic bioequivalence of a TEST formulation of calcipotriene hydrate and betamethasone dipropionate topical suspension 0.005%/0.064% to the RLD.
Are you Suffering from Chronic Plaque Psoriasis?
ActivMed Practices and Research is looking for volunteers to participate in a nationwide study on chronic plaque psoriasis. If you are 18 or older, and have been diagnosed with chronic plaque psoriasis for at least 6 months, you may qualify for this study.
A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3041658 in Patients with Neutrophilic Skin Diseases
Volunteers with neutrophilic skin disease are needed to participate in a research study to assess the safety, tolerability, and activity of an investigational drug that is being developed as a potential treatment for plaque psoriasis, palmoplantar pustulosis, or hidradenitis suppurativa. Eligible participants will be men and women diagnosed with one ...
Scalp psoriasis
We are conducting a research study evaluating the safety and effectiveness of an investigational shampoo for scalp psoriasis. Qualified participants will receive study related exams and study medication at no charge. Please contact us today!
Psoriasis
We are conducting a research study evaluating the safety and effectiveness of an investigational medication for psoriasis. Qualified participants will receive study related exams and study medication at no charge. Please contact us today!
Acne, psoriasis, atopic dermatitis
A 52-week, multicenter, randomized, double-blind study of secukinumab (300mg) to demonstrate efficacy as assessed by psoriasis area and severity index and investigator's global assessment after 12 weeks of treatment, compared to ustekinumab, and to assess long-term safety, tolerability, and efficacy in subjects with moderate to severe plaque psoriasis.
A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the effect of secukinumab on aortic vascular inflammation and cardiometabolic biomarkers after 12 weeks of treatment, compared to placebo, and up to 52 weeks of treatment with secukinumab in adult subjects with moderate to severe chronic plaque-type psoriasis
We are studying an injectable medication, secukinumab, in the treatment of moderate to severe plaque psoriasis. Patients will undergo 3 FDG-PET/CT scans during the study to assess inflammation of the large vessels in the body and the effects of secukinumab on this inflammation. The trial lasts for 52 weeks. Initially ...
